Quorum Review IRB Launches New Program for Phase I Healthy Clinical Trials


Applied Clinical Trials

SEATTLE, WA (July 20, 2015): Quorum Review IRB, the premier central IRB, is introducing a comprehensive program that supports the unique needs of Phase I Healthy clinical trials. Quorum knows that Phase I units require immediate service and quick turnaround times. Quorum’s new program delivers.

With Quorum Review’s new Phase 1 Healthy Program, a study can be ready to enroll participants within a few days of submitting their materials. For changes mid-study, review and delivery of approval documents is even faster. Quorum’s new program also provides unprecedented alternatives in the review of recruitment materials. Quorum can conditionally approve recruitment materials before the protocol review is finalized, so you can more proactively plan for their deployment. If your group leverages generic recruitment templates and generic screening consent forms, Quorum’s new program makes using those materials easier than ever.

Quorum’s customers that have had the opportunity to preview the new Phase 1 Healthy Program proclaim it to be the “most intuitive service offering that exists for Phase 1 Healthy research.” “We know Phase I,” says Quorum’s CEO, Cami Gearhart. “We have Phase I researchers on our IRB panels and staff dedicated to supporting Phase I services. We are proud to offer our clients nimble turnaround times as well as the reliability of a large, accredited IRB.”

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.